top of page
Skyscrapers and Sky


ATXA Therapeutics Limited is a private company limited by shares.

Registered in Ireland No. 561857

Our pipeline is protected by a growing worldwide patent estate and we have secured Orphan Designation from the EMA (Europe) and the FDA (USA) for our lead drug NTP42 for its primary target indication PAH.

Patents 22Apr22.png
bottom of page